A 70-year-old Japanese-American woman, who had never smoked, was diagnosed with T2N2M1 stage IV non-small-cell lung cancer (NSCLC) with rib metastases in April 2002. She had initially presented to ...

The reversible TKIs erlotinib and gefitinib, which selectively target EGFR, were shown to improve disease outcomes in non-small-cell lung cancer (NSCLC) patients with EGFR mutations, and this ...

Find all the commercial and brand names of generic drug called Erlotinib. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...